allow
biochem
structur
character
chymotrypsinlik
main
proteinas
nonstructur
protein
arteriviru
prototyp
equin
arter
viru
eav
develop
protocol
largescal
product
recombin
escherichia
coli
proteinas
express
either
fuse
maltos
bind
protein
carri
ctermin
hexahistidin
tag
follow
purif
moieti
success
use
structur
studi
barretteng
structur
arteriviru
smallest
chymotrypsinlik
proteinas
alphabeta
ctermin
extens
altern
conform
oxyanion
hole
j
biol
chem
furthermor
form
eav
proteinas
shown
proteolyt
activ
two
differ
transcleavag
assay
recombin
cleav
cognat
site
vitro
synthes
substrat
synthet
peptidebas
activ
assay
potenti
recombin
proteinas
cleav
peptid
mimick
residu
six
cleavag
site
investig
peptid
repres
eav
junction
use
optim
reaction
condit
ph
mm
nacl
glycerol
c
result
maximum
turnov
substrat
h
use
substrat
enzym
molar
ratio
assay
describ
studi
use
extens
biochem
character
eav
main
proteinas
includ
studi
aim
identifi
inhibitor
proteolyt
activ
mani
virus
singlestrand
positivesens
rna
genom
regul
genom
express
synthes
larg
precursor
polypeptid
polyprotein
subsequ
subject
limit
proteolysi
produc
function
viral
protein
review
see
dougherti
semler
gorbalenya
snijder
krausslich
wimmer
spall
et
al
rna
viru
polyprotein
includ
replic
protein
often
process
autocatalyt
although
viru
group
cellular
proteinas
also
involv
manner
express
nonstructur
protein
replicas
complex
regul
time
space
eg
produc
altern
cleavag
product
stabl
process
intermedi
uniqu
function
de
groot
et
al
jore
et
al
lemm
et
al
ypmawong
et
al
virus
order
nidoviral
unifi
envelop
positivestrand
arterivirida
coronavirida
ronivirida
spaan
et
al
similar
polycistron
genom
organ
share
conserv
array
homolog
replicas
domain
use
common
transcript
post
translat
strategi
regul
genom
express
among
strategi
one
crucial
proteolyt
matur
replicas
polyprotein
translat
incom
genom
den
boon
et
al
ziebuhr
et
al
equin
arter
viru
eav
prototyp
arteriviru
famili
genom
approxim
kb
fig
proteolyt
process
eav
replicas
process
map
acid
eav
replicas
polyprotein
three
eav
proteinas
cp
sp
cleavag
site
eav
nsp
nomenclatur
depict
papainlik
cy
proteinas
cp
cy
proteinas
sp
ser
proteinas
rdrp
rnadepend
rna
polymeras
z
zinc
finger
hel
helicas
n
nidovirusspecif
endoribonucleas
nendou
b
overview
two
altern
process
pathway
appli
eav
wassenaar
et
al
associ
cleav
probabl
also
shown
cofactor
cleavag
site
proteinas
major
pathway
altern
absenc
site
process
junction
remain
uncleav
minor
pathway
statu
small
subunit
fulli
cleav
partial
associ
andor
remain
elucid
adapt
barretteng
et
al
proxim
three
quarter
contain
replicas
gene
proxim
region
genom
includ
seven
open
read
frame
encod
viral
structur
protein
express
nest
set
subgenom
mrna
de
vri
et
al
snijder
meulenberg
replicas
gene
express
ultim
yield
least
nonstructur
protein
fig
snijder
et
al
van
dinten
et
al
wassenaar
et
al
produc
two
primari
genom
translat
product
larg
polyprotein
amino
acid
amino
acid
latter
express
follow
ribosom
frameshift
event
den
boon
et
al
replicas
subunit
releas
polyprotein
three
virusencod
proteinas
fig
one
locat
respons
process
polypeptid
remain
autocatalyt
releas
snijder
et
al
snijder
et
al
snijder
et
al
van
dinten
et
al
wassenaar
et
al
sinc
control
product
viral
rnadepend
rna
polymeras
rna
helicas
term
eav
main
proteinas
gorbalenya
et
al
ziebuhr
et
al
arteriviru
main
proteinas
belong
serin
proteinas
distinct
group
viral
chymotrypsinlik
proteolyt
enzym
barretteng
et
al
snijder
et
al
ziebuhr
et
al
arteriviru
proteinas
combin
catalyt
triad
hisasps
canon
chymotrypsinlik
proteinas
substrat
specif
cystein
proteinas
subgroup
chymotrypsinlik
enzym
name
picornaviru
proteinas
cleav
eav
equal
eav
replicas
polyprotein
catalyt
triad
form
cleavag
site
recogn
proteinas
carri
glu
p
posit
gln
one
case
small
amino
acid
gli
ser
ala
p
posit
use
cleavag
site
nomenclatur
schechter
berger
furthermor
possess
uniqu
ctermin
domain
ctd
extens
unknown
function
found
chymotrypsinlik
proteinas
might
involv
modul
activ
barretteng
et
al
arteriviru
replic
depend
regul
replicas
gene
express
time
space
play
key
role
notabl
eleg
presum
regulatori
mechan
connect
proteolysi
document
form
differenti
process
part
eav
replicas
polyprotein
fig
wassenaar
et
al
togeth
two
pathway
yield
varieti
product
whose
role
viral
life
cycl
remain
studi
detail
biochem
character
arteriviru
main
proteinas
requir
largescal
express
purif
activ
form
enzym
paper
describ
product
activ
recombin
eav
escherichia
coli
e
coli
allow
design
vitro
cleavag
assay
use
character
properti
interact
substrat
express
system
also
form
basi
structur
studi
led
elucid
threedimension
structur
eav
xray
crystallographi
barretteng
et
al
togeth
studi
major
step
toward
dissect
structurefunct
relationship
key
arteriviru
enzym
futur
design
inhibitor
drug
express
plasmid
construct
use
standard
recombin
dna
techniqu
sequenc
vector
deriv
express
plasmid
new
england
biolab
wassenaar
snijder
unpublish
data
use
strong
tac
promot
male
translat
initi
signal
give
highlevel
express
clone
sequenc
target
gene
pet
plasmid
control
strong
bacteriophag
promot
construct
ncoixhoi
restrict
fragment
plasmid
encod
eav
wassenaar
et
al
clone
plasmid
pbln
molenkamp
result
plasmid
digest
bamhi
xhoi
desir
fragment
clone
uniqu
bamhi
sali
restrict
site
plasmid
encod
eav
proteinas
fuse
cterminu
e
coli
maltos
bind
protein
mbp
asn
spacer
thrombin
cleavag
site
leuvalproargglys
separ
mbp
moieti
fusion
protein
refer
due
clone
strategi
lack
number
contain
three
addit
amino
acid
cterminu
leualas
fig
digest
thrombin
also
nterminu
protein
carri
three
foreign
amino
acid
glysermet
fig
ii
construct
wassenaar
et
al
cell
lysi
ultracentrifug
g
fraction
lane
load
amylos
affin
column
bound
protein
elut
buffer
supplement
mm
maltos
lane
overnight
incub
c
unit
thrombin
per
mg
lane
cleav
purifi
gel
filtrat
sephadex
anion
exchang
chromatographi
repeat
load
sampl
amylos
column
puriti
reach
lane
although
massspectrometri
indic
purifi
homogen
sampl
migrat
doubl
band
repeatedli
observ
phenomenon
protein
separ
sdspage
polyacrylamid
gel
stain
coomassi
brilliant
blue
b
express
purif
sampl
total
lysat
noninduc
lane
iptginduc
lane
cultur
e
coli
cell
transform
fraction
made
purif
lane
cell
lysi
ultracentrifug
fraction
load
talon
affin
column
clontech
charg
cobalt
chlorid
sampl
taken
flowthrough
lane
wash
column
buffer
lane
buffer
supplement
mm
imidazol
lane
bound
elut
column
buffer
e
lane
buffer
composit
see
section
judg
gel
puriti
sampl
c
nucleotideand
amino
acid
sequenc
correspond
termini
gene
express
construct
foreign
amino
acid
shown
bold
face
indic
n
c
top
panel
show
nand
ctermini
wildtyp
produc
eav
replicas
polyprotein
autoproteolysi
site
indic
amino
acid
number
given
middl
panel
show
fusion
protein
cleavag
thrombin
compar
nativ
eav
three
foreign
amino
acid
glysermet
remain
nterminu
amino
acid
sequenc
recogn
thrombin
underlin
posit
thrombin
cleavag
site
indic
cterminu
due
clone
strategi
nativ
replac
leu
residu
two
addit
amino
acid
introduc
alas
bottom
panel
show
protein
translat
initi
codon
ad
result
ntermin
foreign
met
residu
upstream
nativ
p
gli
residu
cterminu
nativ
replac
gli
residu
follow
tag
digest
restrict
enzym
ncoi
stui
desir
fragment
clone
ncoi
bamhidigest
vector
wassenaar
snijder
unpublish
data
togeth
bamhidigest
gli
encod
linker
result
plasmid
encod
addit
met
nterminu
ctermin
tag
fig
precaut
p
residu
cleavag
site
substitut
gli
ensur
tag
would
cleav
result
activ
result
protein
refer
activ
site
mutat
ile
document
inactiv
proteinas
transfer
mutant
protein
use
neg
control
activ
assay
iii
construct
construct
self
ligat
ncoi
smai
digest
plasmid
ncoi
site
fill
use
polymeras
activ
larg
klenow
fragment
dna
polymeras
deriv
sequenc
encod
p
residu
cleavag
site
replac
chang
tyrgluglyleu
leualaserstop
e
coli
strain
carri
iptginduc
rna
polymeras
gene
chromosom
transform
express
plasmid
grown
overnight
ml
luriabertani
liquid
medium
supplement
gml
ampicillin
lba
subsequ
ml
overnight
cultur
use
inocul
flask
contain
l
lba
cultur
grown
c
od
subsequ
protein
express
induc
ad
mm
iptg
bacteria
harvest
h
induct
centrifug
g
min
cell
pellet
store
c
directli
use
process
purif
procedur
sampl
buffer
kept
c
pellet
cell
resuspend
buffer
mm
tri
ph
mm
nacl
mm
edta
lyse
pass
twice
k
french
pressur
cell
slmaminco
psi
mpa
subsequ
lysat
centrifug
g
min
result
supernat
pellet
fraction
fraction
load
onto
amylos
affin
column
new
england
biolab
wash
buffer
od
flowthrough
drop
subsequ
bound
fusion
protein
elut
column
fraction
use
buffer
supplement
mm
maltos
fraction
contain
fusion
protein
determin
sdspage
analysi
pool
concentr
fusion
protein
determin
use
bradford
protein
assay
biorad
gener
l
cultur
yield
mg
fusion
protein
fusion
proteincontain
fraction
dilut
concentr
mgml
incub
h
c
unit
thrombin
human
plasma
sigma
per
mg
fusion
protein
dialysi
buffer
b
mm
tri
ph
mm
nacl
mm
edta
c
cleav
fusion
protein
load
onto
anion
exchang
column
mono
q
hr
pharmacia
wash
extens
buffer
b
remov
trace
maltos
contamin
protein
bound
protein
elut
column
fraction
use
ml
gradient
mm
nacl
mm
tri
ph
l
mm
edta
fraction
pool
concentr
mgml
ml
fraction
load
onto
sephadex
gel
filtrat
column
total
bed
volum
ml
fraction
column
contain
repeatedli
load
onto
amylos
affin
column
detect
trace
mbp
judg
sdspage
coomassi
brilliant
blue
stain
remov
prepar
dilut
buffer
b
concentr
mgml
store
c
puriti
integr
sampl
confirm
mass
spectrometri
e
coli
strain
transform
express
plasmid
singl
coloni
incub
ml
lba
c
cultur
becam
turbid
approxim
h
subsequ
l
cultur
plate
lba
agar
plate
incub
overnight
c
plate
slice
small
piec
ad
flask
contain
ml
lba
cultur
grown
od
subsequ
protein
express
induc
mm
iptg
bacteria
harvest
h
induct
centrifug
g
min
c
cell
pellet
either
store
c
immedi
use
process
purif
procedur
sampl
buffer
kept
c
cell
resuspend
buffer
c
mm
phosphat
ph
mm
nacl
lyse
centrifug
use
method
describ
purif
fraction
load
onto
talon
metal
affin
resin
clontech
column
total
bed
volum
ml
column
wash
buffer
c
od
flowthrough
drop
subsequ
column
wash
column
volum
buffer
mm
tri
ph
mm
nacl
column
volum
buffer
supplement
mm
imidazol
wash
nonspecif
bound
protein
elut
column
buffer
e
mm
tri
ph
mm
nacl
mm
imidazol
pure
judg
coomassi
brilliant
blue
stain
protein
gel
gener
yield
mg
per
cultur
obtain
prepar
dilut
buffer
g
mm
tri
ph
mm
nacl
concentr
mgml
store
c
use
tnt
system
promega
plasmid
encod
eav
respect
vitro
transcrib
result
rna
translat
presenc
methionin
amersham
typic
transcriptiontransl
reaction
volum
l
carri
min
c
reaction
stop
ad
volum
stopmix
mm
methionin
mgml
cycloheximid
sigma
gml
rnase
l
reaction
incub
g
either
purifi
nonpurifi
cleav
mm
tri
ph
contain
mm
nacl
total
volum
l
sampl
l
taken
regular
interv
min
addit
proteinas
reaction
product
analyz
tricin
gel
neg
control
g
purifi
use
enzym
reaction
peptid
substrat
synthes
solidphas
strategi
autom
multipl
peptid
synthes
syroii
multisyntech
witten
germani
puriti
peptid
determin
analyt
reversedphas
hplc
prove
least
ident
homogen
peptid
determin
matrixassist
laser
desorpt
ioniz
timeofflight
mass
spectrometri
analyt
reversedphas
chromatographi
peptid
repres
residu
cleavag
site
synthes
solidphas
chemistri
tabl
peptid
dissolv
dmso
concentr
gl
store
c
activ
assay
perform
reaction
volum
l
use
l
gl
l
peptid
gl
appropri
buffer
yield
final
concentr
gl
gl
peptid
assay
cleavag
reaction
routin
incub
c
h
reaction
termin
addit
l
trifluoroacet
acid
store
c
prior
analysi
hplc
sampl
centrifug
min
g
remov
insolubl
compon
cleavag
product
resolv
use
min
linear
gradient
acetonitril
trifluoroacet
acid
absorb
determin
nm
peak
area
calcul
integr
largescal
express
purif
fusion
protein
achiev
use
protocol
describ
section
briefli
induct
express
larg
amount
fusion
protein
recov
solubl
fraction
fig
purif
protein
use
amylos
resin
affin
column
yield
pure
fusion
protein
judg
coomassi
brilliant
blue
stain
protein
gel
prevent
exposur
proteinas
rel
high
temperatur
releas
mbp
moieti
cleavag
thrombin
perform
recommend
temperatur
c
c
overnight
digest
unit
thrombin
per
mg
fusion
protein
suffici
cleav
virtual
fusion
protein
fig
purifi
anion
exchang
chromatographi
gel
filtrat
repeat
load
sampl
onto
amylos
resin
affin
column
remov
remain
trace
mbp
due
clone
strategi
lack
ctermin
residu
number
carri
three
addit
amino
acid
extrem
cterminu
leualas
cleavag
thrombin
also
nterminu
proteinas
remain
attach
three
foreign
residu
glysermet
fig
although
mass
spectrometri
indic
purifi
sampl
homogen
expect
molecular
mass
two
band
visibl
gel
fig
recogn
antiserum
data
shown
report
predict
molecular
mass
kda
migrat
kda
protein
presum
prone
aberr
migrat
sdspage
nevertheless
recombin
protein
obtain
use
protocol
suffici
puriti
homogen
success
use
crystallogenesi
subsequ
structur
determin
xray
crystallographi
barretteng
et
al
altern
use
mbp
fusion
protein
decid
employ
product
ctermin
tag
protein
second
expressionpurif
strategi
peptid
contain
protect
b
amid
cterminu
b
c
cystein
residu
replac
acid
previous
use
success
purifi
mani
proteinas
includ
sever
proteinas
group
chisholm
et
al
someya
et
al
tibbl
et
al
base
specif
affin
histidin
residu
cobalt
ion
conveni
onestep
purif
could
perform
use
chelat
agaros
column
charg
cobalt
chlorid
reason
tag
purif
could
effici
compar
mbpmediat
purif
circumv
potenti
harm
thrombin
treatment
includ
labori
remov
mbp
protocol
describ
essenti
follow
origin
manufactur
protocol
ctermin
tag
protein
describ
section
howev
adjust
made
regard
induct
protein
express
overnight
liquid
cultur
e
coli
bacteria
use
inocul
larger
cultur
induct
protein
express
iptg
unknown
reason
success
howev
synthesi
could
induc
cultur
grown
shorter
period
time
coloni
pick
freshli
transform
plate
therefor
instead
use
overnight
liquid
cultur
inoculum
droplet
h
cultur
plate
lba
plate
incub
overnight
c
slice
small
piec
ad
lbacontain
flask
method
larg
cultur
could
grown
right
densiti
short
period
time
harvest
lysi
centrifug
cell
fraction
load
column
pack
talon
metal
affin
resin
clontech
charg
cobalt
ion
column
wash
extens
sever
buffer
see
section
remov
contamin
protein
elut
column
protein
pure
judg
coomassi
brilliant
blue
stain
sdspage
gel
gener
yield
mg
protein
per
cultur
obtain
fig
activ
site
mutant
purifi
use
protocol
yield
compar
quantiti
protein
expressionand
purif
protocol
could
purifi
within
h
wherea
express
cleavag
purif
protocol
would
gener
take
day
differ
amino
acid
sequenc
nand
ctermini
express
product
comparison
termini
nativ
eav
depict
fig
test
whether
activ
recombin
proteinas
isol
proteolyt
activ
purifi
test
cleavag
assay
use
vitro
synthes
substrat
describ
section
substrat
repres
eav
natur
occur
process
intermedi
minor
process
pathway
wassenaar
et
al
aliquot
vitro
translat
reaction
incub
purifi
recombin
sampl
taken
min
addit
proteinas
analyz
tricin
sdspage
gel
fig
process
two
substrat
could
easili
monitor
sinc
cleavag
site
result
fig
eav
activ
vitro
cleavag
assay
use
tnt
system
promega
express
plasmid
encod
eav
vitro
transcrib
result
rna
vitro
translat
rabbit
reticulocyt
lysat
presenc
methionin
incub
c
transcript
translat
stop
detail
see
section
subsequ
typic
l
reaction
aliquot
taken
incub
g
purifi
neg
control
min
total
reaction
volum
l
sampl
analyz
tricin
gel
label
product
detect
autoradiographi
use
phosphoimag
biorad
vitro
assay
yield
expect
process
product
predict
known
cleavag
site
addit
number
smaller
cleavag
product
detect
indic
arrow
may
deriv
intern
cleavag
see
text
process
product
detect
due
small
size
kda
respect
substrat
size
reduct
kda
respect
fig
illustr
incub
half
substrat
process
although
remain
substrat
process
much
slower
similar
result
regard
process
site
obtain
substrat
second
cleavag
site
substrat
site
process
much
faster
alreadi
min
almost
could
detect
suggest
site
cleav
avail
substrat
fig
surprisingli
process
substrat
produc
sever
addit
product
indic
arrow
fig
observ
incub
inact
control
enzym
reaction
perform
without
enzym
suggest
gener
product
depend
proteolyt
activ
base
size
product
may
deriv
intern
cleavag
possibl
current
investig
detail
use
ident
experiment
setup
partial
purifi
cleav
uncleav
also
test
proteinas
activ
assay
differ
could
observ
two
proteinas
display
activ
similar
taken
togeth
result
confirm
activ
eav
proteinas
purifi
e
coli
vitro
cleavag
assay
describ
previou
paragraph
less
use
quantit
biochem
analysi
catalyt
activ
sinc
quantif
substrat
straightforward
consequ
altern
assay
base
use
synthet
peptid
substrat
develop
use
approach
like
proteinas
like
human
coronaviru
felin
infecti
periton
viru
sever
picornavirus
cordingley
et
al
hammerl
et
al
hegyi
et
al
jewel
et
al
ziebuhr
et
al
success
character
set
peptid
tabl
mimick
p
posit
six
cleavag
site
downstream
ziebuhr
et
al
synthes
peptid
test
potenti
cleav
initi
experi
g
peptid
final
concentr
approxim
incub
c
g
either
concentr
without
proteinas
volum
buffer
contain
mm
tri
ph
mm
nacl
mm
edta
sampl
taken
directli
addit
h
incub
analyz
reversedphas
hplc
exampl
result
peptid
repres
cleavag
site
shown
fig
follow
incub
main
peak
repres
uncleav
peptid
reduc
peptid
appar
convert
two
new
product
incub
assay
without
yield
two
new
peak
indic
deriv
activ
mass
spectrometri
use
analyz
two
newli
form
product
found
peak
retent
time
min
fig
mass
ctermin
ntermin
fragment
peptid
respect
assum
cleavag
glugli
bond
repres
establish
eav
cleavag
site
substrat
peptid
could
cleav
select
condit
approxim
hydrolysi
h
without
obviou
differ
peptid
detect
data
shown
peptid
repres
cleavag
site
select
optim
reaction
condit
slightli
higher
cleavag
potenti
although
purifi
eav
proteinas
show
catalyt
activ
peptid
activ
weak
compar
proteinas
similar
experi
cordingley
et
al
hammerl
et
al
hegyi
et
al
jewel
et
al
ziebuhr
et
al
therefor
investig
whether
differ
purifi
proteinas
might
perform
better
catalyt
activ
proteinas
compar
partial
purifi
proteinas
protein
purifi
thrombin
cleavag
step
instead
cleav
fusion
protein
sampl
directli
use
peptid
cleavag
assay
similar
experiment
setup
use
hcv
shown
limit
purif
neg
affect
abil
proteinas
cleav
peptid
ziebuhr
et
al
howev
enzymat
properti
partial
purifi
eav
differ
tag
proteinas
data
shown
suggest
low
catalyt
activ
differ
caus
possibl
inhibit
proteinas
contamin
instabl
enzym
storag
investig
addit
wash
column
fig
eav
activ
vitro
cleavag
assay
use
synthet
peptid
substrat
one
hundr
micromolar
peptid
incub
accord
protocol
describ
section
reaction
product
analyz
revers
phase
hplc
result
shown
reaction
without
proteinas
panel
reaction
ad
panel
b
use
mass
spectrometri
peak
retent
time
min
hplc
profil
sampl
incub
identifi
cterminaland
ntermin
fragment
respect
peptid
substrat
isopropanol
franken
et
al
use
purifi
protein
directli
assay
instead
storag
c
c
howev
addit
wash
step
increas
catalyt
activ
differ
found
freshli
prepar
sampl
prepar
store
c
day
store
c
week
indic
catalyt
activ
lost
storag
alreadi
low
upon
isol
enzym
possibl
due
purif
method
andor
intrins
properti
altern
paramet
vitro
cleavag
reaction
might
suboptim
address
latter
possibl
catalyt
activ
compar
differ
temperatur
c
use
start
buffer
composit
mm
tri
ph
mm
nacl
mm
edta
although
hydrolysi
peptid
turn
slightli
faster
c
differ
comparison
temperatur
margin
data
shown
attempt
optim
condit
cleavag
assay
g
peptid
final
concentr
incub
g
final
concentr
volum
l
c
differ
buffer
vari
systemat
ph
nacl
glycerol
concentr
ph
rang
test
includ
mm
me
mm
mop
mm
tri
mm
glycin
ph
valu
combin
nacl
concentr
mm
glycerol
concentr
incub
reaction
stop
ad
l
trichloroacit
acid
sampl
analyz
use
reversedphas
hplc
sinc
peak
retent
time
min
repres
ctermin
part
peptid
low
absorb
nm
peak
retent
time
min
fig
quantifi
integr
sampl
could
quantifi
less
substrat
cleav
although
differ
catalyt
activ
observ
use
differ
buffer
signific
improv
found
compar
start
reaction
condit
substrat
cleav
incub
c
ph
buffer
nacl
concentr
mm
catalyt
activ
even
detect
limit
signific
differ
found
reaction
perform
ph
catalyt
activ
seem
slightli
enhanc
increas
concentr
glycerol
data
shown
sinc
high
nacl
concentr
inhibit
activ
cleavag
condit
optim
titrat
nacl
concentr
increment
mm
ph
mm
mop
glycerol
concentr
although
catalyt
activ
slightli
higher
glycerol
concentr
lower
concentr
chosen
technic
reason
howev
increas
nacl
concentr
mm
reduc
catalyt
activ
assay
data
shown
final
effect
presenc
mm
dtt
mm
edta
catalyt
activ
investig
addit
compound
make
detect
differ
data
shown
report
describ
two
protocol
express
purif
recombin
eav
two
approach
assess
proteolyt
activ
purifi
enzym
vitro
purif
protocol
result
isol
highli
pure
proteinas
conclus
support
subsequ
use
moieti
crystal
structur
studi
barretteng
et
al
result
assay
use
substrat
synthes
rabbit
reticulocyt
lysat
show
proteinas
abl
process
cognat
cleavag
site
substrat
indic
activ
enzym
purifi
although
quantit
assay
eav
proteinas
display
kinet
compar
proteinas
similar
experi
grubman
et
al
thole
hull
tibbl
et
al
tibbl
et
al
ziebuhr
et
al
unexpect
small
reaction
product
visibl
fig
first
suggest
aberr
activ
addit
cleavag
proteinas
system
possibl
follow
activ
howev
reexamin
protein
gel
sever
previou
independ
experi
use
express
system
eavinfect
cell
investig
activ
confirm
exist
minor
band
approxim
size
unidentifi
band
fig
make
plausibl
band
deriv
genuin
activ
elabor
analysi
presenc
intern
cleavag
site
present
elsewher
van
aken
et
al
manuscript
prepar
character
catalyt
activ
detail
assay
use
synthet
peptid
substrat
develop
optim
cleavag
assay
prefer
purif
latter
elabor
process
although
report
addit
six
residu
strongli
inhibit
enzymat
activ
human
coronaviru
pro
proteinas
ziebuhr
et
al
assay
catalyt
activ
compar
partial
purifi
uncleav
cleav
also
vivo
transcleavag
activ
determin
use
recombin
vaccinia
express
system
data
shown
compar
untag
suggest
presenc
tag
affect
proteolyt
activ
although
process
kinet
vitro
synthes
substrat
seem
compar
eg
distantli
relat
human
coronaviru
pro
ident
experiment
setup
true
synthet
peptid
cleavag
assay
despit
effort
improv
perform
enzym
test
varieti
reaction
condit
unabl
cleav
substrat
incub
wherea
studi
use
human
coronaviru
sarscoronaviru
pro
enzym
report
complet
convers
compar
amount
substrat
less
h
use
lower
enzym
concentr
compar
use
experi
shi
et
al
ziebuhr
et
al
possibl
explan
discrep
lack
assay
suggest
act
cofactor
polyprotein
process
via
major
pathway
vivo
wassenaar
et
al
flavivirida
famili
cofactor
hepat
c
viru
cofactor
dengu
viru
type
shown
enhanc
vitro
proteinas
activ
steinkuhl
et
al
yusof
et
al
yet
anoth
explan
may
found
observ
made
crystallograph
studi
barretteng
et
al
report
three
four
copi
unit
cell
collaps
oxyanion
hole
would
render
proteinas
practic
inact
major
purifi
molecul
would
collaps
oxyanion
hole
might
explain
low
activ
proteinas
possibl
consequ
express
e
coli
sinc
form
proteinas
display
low
proteolyt
activ
express
differ
system
eg
insect
cell
yeast
might
give
better
result
also
rule
foreign
amino
acid
residu
present
either
cterminu
recombin
might
inhibit
proteolyt
activ
coronaviru
main
proteinas
nterminu
found
critic
import
geometri
particular
subsit
suggest
chang
extens
part
protein
may
advers
influenc
proteolyt
activ
anand
et
al
properti
share
distantli
relat
arteriviru
main
proteinas
might
explain
find
collaps
oxyanion
hole
barretteng
et
al
major
molecul
although
seem
either
small
part
purifi
proteolyt
activ
catalyt
activ
enzym
low
cleavag
cognat
site
assay
confirm
specif
e
colideriv
proteinas
thu
work
describ
studi
may
lay
groundwork
extens
biochem
character
eav
main
proteinas
includ
studi
aim
identifi
inhibitor
proteolyt
activ
